2018 POC/Point-of-Care PT and APTT Testing Market: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers

  • ID: 4564608
  • Report
  • 366 pages
  • VPG Market Research
1 of 3

FEATURED COMPANIES

  • Abbott
  • Axis-Shield
  • Bio/Data Corporation
  • Grifols
  • Roche
  • Sysmex
  • MORE

This new 366-page report contains 39 tables, and provides a comprehensive analysis of the PT and APTT testing in POC locations, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC coagulation market.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation Analysis

- Review of nine POC market segments, including their dynamics, trends, structure, size, growth and major suppliers.

- Five-year test volume and reagent sales forecasts for coagulation procedures
by market segment:
- Physician Offices/Group Practices
- Emergency Rooms
- Operating/Recovery Suites
- ICUs/CCUs
- Cancer Clinics
- Ambulatory Care Centers
- Surgery Centers
- Nursing Homes
- Birth Centers

Sales and Market Share Analysis

- Sales and market shares of major reagent and instrument suppliers.

Current and Emerging Products

- Analysis of coagulation procedures performed in POC testing locations.
- Review of leading coagulation analyzers, both currently marketed and
those in development, including their operating characteristics, features and selling prices.

Technology Review

- Emerging technologies and their applications for POC testing.
- Comprehensive listings of companies developing or marketing coagulation
testing technologies and products, by assay.

Competitive Assessments

- Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.

Strategic Recommendations

- Specific opportunities for new coagulation instruments and reagent systems with potentially
significant market appeal during the next five years.

- Design criteria for POC testing products.
- Alternative business expansion strategies.
- Potential market entry barriers and risks.

Methodology

This report is based on a combination of primary and secondary sources of information, including review of the latest technical and business publications, manufacturer product literature, industry analyst reports, and proprietary data files.

Contains 366 pages and 39 tables

READ MORE
Note: Product cover images may vary from those shown
2 of 3

Loading
LOADING...

3 of 3
  • Abbott
  • Accriva
  • ADI/American Diagnostica/Sekisui
  • Alere/Biosite/Inverness
  • Axis-Shield
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Bio/Data Corporation
  • Chrono-Log
  • Corgenix Medical
  • Diagnostica Stago/Trinity Biotech
  • Grifols
  • Helena Laboratories
  • HYPEN BioMed
  • Instrumentation Laboratory
  • Roche
  • Siemens
  • Sienco
  • Sysmex
  • Thermo Fisher
  • ZyCare/Alere
Note: Product cover images may vary from those shown
4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll